Senior insider sale
Chief Financial Officer at PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$7.13M
79.56K shares
What this filing means
ALI ASIF plans to sell 79.56K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $7.13M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/26/2026ACC: 0001950047-26-003018
Officer· Chief Financial Officer
Since Apr 2022
79.56K
Shares to sell
$7.13M
Approx. market value
24.77K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
3/26/2026
24.77KTotal acquired24.77K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/26/2026 | Stock Option Exercise Cash | 24.77K | — |
| Total | 24.77K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
46.20K
Market value
$3.84M
1/27/2026
—Completed
Units to sell
8.59K
Market value
$708.3K
1/20/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
24.77K
Market value
$2.58M
3/26/2026
Total
Units
79.56K
Value
$7.13M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/27/2026 | 46.20K | $3.84M | — | Completed |
1/20/2026 | 8.59K | $708.3K | — | Completed |
| Planned — Approximate Date | ||||
3/26/2026 | 24.77K | $2.58M | NASDAQ | Planned |
| Total | 79.56K | $7.13M | ||